A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia
Clinical trial NCT04109950 · TERMINATED
Trial details
- NCT number
- NCT04109950
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-20
- Primary completion
- 2023-11-09
- Enrollment
- 463
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.